Denali Therapeutics' IPO

Denali Therapeutics raised a round of funding on December 08, 2017. Investors include Public.

Denali Therapeutics is a privately held biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinso…

Articles about Denali Therapeutics' IPO: